Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.

Autor: Moore KN, Tian C, McMeekin DS, Thigpen JT, Randall ME, Gallion HH
Zdroj: Cancer (0008543X); 12/1/2010, Vol. 116 Issue 23, p5407-5414, 8p
Databáze: Complementary Index
Externí odkaz: